Myotonia congenita and myotonic dystrophy: surveillance and management.

Abstract

OPINION STATEMENT:

Myotonia can be treated both pharmacologically and by lifestyle modifications. Cell membrane stabilizers are the medications most commonly used for symptomatic treatment of myotonia. Most patients do not require treatment for the myotonia itself, unless it is severe, but physicians must be aware of anesthesia risks in both myotonia congenita and myotonic dystrophy. A mainstay of management of myotonic dystrophy is the surveillance and treatment of its various systemic complications.

• Authors: Allison Conravey, Lenay Santana-Gould
• Journal: Current treatment options in neurology (Curr Treat Options Neurol) Vol. 12 Issue 1 Pg. 16-28 (Jan 2010) ISSN: 1534-3138 [Electronic] United States
• PMID: 20842486 (Publication Type: Journal Article)